Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Nabi (NABI) -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (321)	3/2/2002 8:34:34 AM
From: NRugg	Respond to of 354

Thank you for prompt response. I have been away from home base, can read mail and postings but can't copy or past things. David Gury, the CEO, also rsponded pronptly.He complimented me on my analysis, but does not sem very enthusiastic. Here is a partial quote, retyped. "Our strategy is to license the vaccine to an organization thta has an animal focus from a development from a development standpoint and from a sales and marketing capability. We believe that this will give us the greatest opportunity to benefit from the technology with royalties from another organization." He certainly is in better position than me to estimate cost of manufacture, and probably has a bettter estimate of how effective the drug will be in reducing infections. Norman